13 Feb 2023 , 03:37 PM
Sun Pharma Industries Limited informed that it is recalling more than 34,000 bottles of generic medication in the US market due to failed dissolution testing. This medicine is used to treat high blood pressure.
According to the US Food and Drug Administration's Enforcement Report, Sun Pharmaceutical Industries' US-based arm is recalling large quantities of Diltiazem Hydrochloride extended-release capsules, which are used to treat angina, some types of irregular heartbeats, and high blood pressure.
The pharmaceutical company located in New Jersey has taken the decision to recall a specific batch of their product due to a failure in impurity control (Deacetyl Diltiazem Hydrochloride) during stability tests, as well as subpar results in dissolution testing as determined by the USFDA’s laboratory.
The lot was manufactured at the Mumbai-based drugmaker's Halol-based manufacturing facility in Gujarat. The affected lot was later supplied in the market by the company's US-based subsidiary.
On January 13, this year, the company began the Class II nationwide recall (US).
The USFDA explains that a Class II recall is called into action when a product that violates their standards may result in health problems that can be fixed with medical intervention, or when the likelihood of severe health consequences is low.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.